Insufficient scRNA-seq data for expression of PGLYRP1 at single-cell level.
Insufficient scRNA-seq data for expression of PGLYRP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 226.90 | 566 / 578 | 11% | 0.31 | 131 / 1155 |
spleen | 100% | 1142.38 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 7343.08 | 851 / 929 | 0% | 0 | 0 / 0 |
liver | 82% | 35.82 | 186 / 226 | 1% | 0.03 | 6 / 406 |
brain | 63% | 12.39 | 1653 / 2642 | 10% | 0.23 | 73 / 705 |
kidney | 58% | 16.61 | 52 / 89 | 9% | 0.21 | 82 / 901 |
thymus | 61% | 14.55 | 401 / 653 | 5% | 0.09 | 29 / 605 |
adipose | 63% | 24.97 | 756 / 1204 | 0% | 0 | 0 / 0 |
stomach | 36% | 9.58 | 129 / 359 | 26% | 0.50 | 73 / 286 |
heart | 59% | 20.24 | 512 / 861 | 0% | 0 | 0 / 0 |
esophagus | 30% | 6.07 | 438 / 1445 | 25% | 0.50 | 46 / 183 |
breast | 48% | 10.05 | 221 / 459 | 3% | 0.08 | 33 / 1118 |
adrenal gland | 34% | 5.56 | 88 / 258 | 16% | 0.36 | 36 / 230 |
uterus | 45% | 7.95 | 76 / 170 | 5% | 0.09 | 22 / 459 |
intestine | 31% | 6.33 | 300 / 966 | 17% | 0.41 | 92 / 527 |
bladder | 29% | 5.57 | 6 / 21 | 11% | 0.24 | 57 / 504 |
blood vessel | 37% | 8.68 | 493 / 1335 | 0% | 0 | 0 / 0 |
ovary | 25% | 3.90 | 45 / 180 | 8% | 0.14 | 34 / 430 |
prostate | 28% | 4.42 | 69 / 245 | 3% | 0.04 | 14 / 502 |
muscle | 29% | 4.70 | 235 / 803 | 0% | 0 | 0 / 0 |
skin | 23% | 2.84 | 420 / 1809 | 4% | 0.06 | 19 / 472 |
pancreas | 14% | 1.57 | 45 / 328 | 7% | 0.14 | 12 / 178 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.17 | 4 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051701 | Biological process | biological process involved in interaction with host |
GO_0016045 | Biological process | detection of bacterium |
GO_0045087 | Biological process | innate immune response |
GO_0032827 | Biological process | negative regulation of natural killer cell differentiation involved in immune response |
GO_0007165 | Biological process | signal transduction |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0009253 | Biological process | peptidoglycan catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0097013 | Cellular component | phagocytic vesicle lumen |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0016019 | Molecular function | peptidoglycan immune receptor activity |
GO_0008745 | Molecular function | N-acetylmuramoyl-L-alanine amidase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
Gene name | PGLYRP1 |
Protein name | Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S) |
Synonyms | TNFSF3L PGRP UNQ639/PRO1269 SBBI68 PGLYRP |
Description | FUNCTION: Innate immunity protein that plays several important functions in antimicrobial and antitumor defense systems. Acts as a pattern receptor that binds to murein peptidoglycans (PGN) of Gram-positive bacteria and thus provides bactericidal activity . Forms an equimolar complex with heat shock protein HSPA1A and induces programmed cell death through apoptosis and necroptosis in tumor cell lines by activating the TNFR1 receptor on the target cell membrane . In addition, acts in complex with the Ca(2+)-binding protein S100A4 as a chemoattractant able to induce lymphocyte movement . Mechanistically, this complex acts as a ligand of the chemotactic receptors CCR5 and CXCR3 which are present on the cells of the immune system . Promotes also the activation of lymphocytes that become able to kill virus-infected cells as well as tumor cells by modulating the spectrum of their target-cell specificity . Induction of cytotoxicity on monocyte surface requires interaction with TREM1 receptor . . |
Accessions | ENST00000008938.5 O75594 |